Want to see IN:BAYERCROP full AI Analyst Report?
Top Page
Bayer Cropscience India Limited
(BAYERCROP)
Select Model
Select Model
Rating:68Neutral
Price Target:
₹4,433.00
▲(8.39% Upside)
Action:Reiterated
Date:08/28/26
The score is driven primarily by strong financial quality—especially the very low-debt balance sheet and solid profitability—tempered by margin/cash-flow volatility. Technical indicators are weak with the stock trading below key moving averages and negative MACD, while valuation is supported by a strong dividend yield but constrained by a ~25 P/E.
Positive Factors
Very low financial leverage
Minimal debt reduces interest and refinancing risk, preserves liquidity through agricultural cycles, and gives Bayer CropScience India flexibility to fund distribution, product development, and growth without materially increasing balance-sheet strain.
Negative Factors
Margin compression from prior peaks
Lower margins than the earlier peak period suggest that profitability has not been fully sustained, potentially reflecting product mix, input costs, competition, or pricing pressure and limiting the durability of future earnings growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Very low financial leverage
Minimal debt reduces interest and refinancing risk, preserves liquidity through agricultural cycles, and gives Bayer CropScience India flexibility to fund distribution, product development, and growth without materially increasing balance-sheet strain.
Read all positive factors
Bayer Cropscience India Limited (BAYERCROP) vs. iShares MSCI India ETF (INDA)
Market Cap
₹178.85B
Dividend Yield3.77%
Average Volume (3M)1.37K
Price to Earnings (P/E)24.4
Beta (1Y)0.79
Revenue Growth-2.78%
EPS Growth23.56%
CountryIN
Employees1,317
SectorGeneral
Sector StrengthN/A
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)162.90
Shares Outstanding44,942,093
10 Day Avg. Volume1,213
30 Day Avg. Volume1,368
Financial Highlights & Ratios
PEG Ratio1.42
Price to Book (P/B)7.04
Price to Sales (P/S)3.68
P/FCF Ratio19.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)169.94
Revenue Forecast (FY)₹60.29B
Bayer Cropscience India Limited Business Overview & Revenue Model
Company Description
Bayer CropScience Limited, founded in Thane, India, in 1958, is a diversified enterprise involved in various sectors, including agriculture, pharmaceuticals, and consumer health, with a global reach encompassing India, Germany, and Bangladesh, amo...
How the Company Makes Money
Bayer CropScience India Limited primarily makes money by selling agricultural inputs in India, with revenue largely derived from the sale of crop protection products (e.g., insecticides, herbicides, fungicides and other plant protection solutions)...
Bayer Cropscience India Limited Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
90
Very Positive
Cash Flow
68
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.95B | 56.75B | 54.73B | 51.06B | 51.40B | 47.34B |
| Gross Profit | 22.08B | 17.65B | 20.59B | 21.81B | 23.09B | 20.57B |
| EBITDA | 10.58B | 9.69B | 6.43B | 9.43B | 8.86B | 7.90B |
| Net Income | 7.32B | 6.89B | 5.68B | 7.41B | 7.58B | 6.45B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 56.99B | 52.46B | 45.97B | 46.79B | 43.53B |
| Cash, Cash Equivalents and Short-Term Investments | 14.72B | 14.79B | 9.29B | 12.11B | 9.02B | 8.19B |
| Total Debt | 0.00 | 818.00M | 1.05B | 471.00M | 735.00M | 864.00M |
| Total Liabilities | -29.66B | 27.34B | 23.95B | 17.48B | 19.66B | 18.29B |
| Stockholders Equity | 29.66B | 29.66B | 28.50B | 28.49B | 27.12B | 25.24B |
Cash Flow | ||||||
| Free Cash Flow | -682.00M | 10.57B | 2.59B | 9.06B | 5.32B | 1.60B |
| Operating Cash Flow | -349.00M | 10.97B | 3.00B | 9.52B | 6.09B | 2.15B |
| Investing Cash Flow | -90.00M | 414.00M | 389.00M | 4.00M | 833.00M | 642.00M |
| Financing Cash Flow | -1.84B | -6.12B | -6.10B | -6.56B | -6.13B | -7.03B |
Bayer Cropscience India Limited Technical Analysis
Negative
4089.90
Price Trends
4103.22
Negative
4229.04
Negative
4363.73
Negative
Market Momentum
-45.31
Positive
40.13
Neutral
42.95
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BAYERCROP, the sentiment is Negative. The current price of 4089.9 is above the 20-day moving average (MA) of 4029.45, below the 50-day MA of 4103.22, and below the 200-day MA of 4363.73, indicating a bearish trend. The MACD of -45.31 indicates Positive momentum. The RSI at 40.13 is Neutral, neither overbought nor oversold. The STOCH value of 42.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BAYERCROP.
Bayer Cropscience India Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹39.48B | 18.38 | ― | 1.49% | 4.41% | 24.42% | |
71 Outperform | ₹70.46B | 11.03 | ― | 1.96% | 18.52% | 49.11% | |
68 Neutral | ₹178.85B | 24.40 | ― | 3.77% | -2.78% | 23.56% | |
67 Neutral | ₹43.83B | 16.48 | ― | 0.20% | -5.63% | -11.38% | |
58 Neutral | ₹484.43B | 23.94 | ― | 1.05% | 12.86% | 72.26% | |
56 Neutral | ₹358.02B | 29.41 | ― | 0.44% | -16.57% | -27.71% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IN:BAYERCROP
Bayer Cropscience India Limited
3,980.00
-954.47
-19.34%
IN:DHANUKA
Dhanuka Agritech Limited
980.30
-581.24
-37.22%
IN:PIIND
PI Industries Limited
2,257.50
-1,422.67
-38.66%
IN:RALLIS
Rallis India Limited
202.00
-126.25
-38.46%
IN:SHARDACROP
Sharda Cropchem Ltd.
766.05
-103.29
-11.88%
IN:UPL
UPL Limited
573.85
-112.31
-16.37%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.